Global Monoclonal Antibody Therapeutics Market to Reach US$501.5 Billion by 2030, Driven by Rising Chronic Diseases and R&D Investment
Monoclonal antibodies, commonly known as moAbs or mAbs, are lab-made proteins that function in human bodies similarly to antibodies. Your immune system includes antibodies as …